Kanish Mirchia

17PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical infection agents (incl. prions)Predictive and prognostic markersNeurosciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.

|Apr 13, 2026
IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.

Jacob S Young, Nam Woo Cho, Calixto-Hope G Lucas

|Jan 30, 2026
A case of radiation treatment effect mimicking viable, recurrent meningioma on DOTATATE PET imaging.

Brooke C Braman, Kanish Mirchia, Javier E Villanueva-Meyer

|Jul 02, 2025
Pan-cancer copy number analysis identifies optimized size thresholds and co-occurrence models for individualized risk stratification.

Minh P Nguyen, William C Chen, Kanish Mirchia

|Dec 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannoma.

Simone Schmid, Kanish Mirchia, Anna Tietze

|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution.

Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo

Pageof 3

Frequent Collaborators

7 joint publications

David Raleigh

5 joint publications

Calixto-Hope Lucas

5 joint publications

Arie Perry

5 joint publications

William Chen